Underwriting Agreements in the Pharmaceuticals Industry

905 Contracts & Agreements

Browse by Company

60 DEGREES PHARMACEUTICALS, INC. (5 contracts)
Accelerated Pharma, Inc. (3)
ACELRX PHARMACEUTICALS INC (3)
Acer Therapeutics Inc. (6)
ACHILLION PHARMACEUTICALS INC (5)
Aclaris Therapeutics, Inc. (6)
Adamis Pharmaceuticals Corp (6)
ADIAL PHARMACEUTICALS, INC. (7)
Aegerion Pharmaceuticals, Inc. (4)
AEON Biopharma, Inc. (1)
AERIE PHARMACEUTICALS INC (3)
Aerpio Pharmaceuticals, Inc. (1)
AGILE THERAPEUTICS INC (6)
Akers Biosciences, Inc. (4)
ALDER BIOPHARMACEUTICALS INC (7)
Alexza Pharmaceuticals Inc. (1)
ALGORX PHARMACEUTICALS INC (2)
ALIMERA SCIENCES INC (1)
Allergan, plc (3)
Amag Pharmaceuticals (6)
Amphastar Pharma (1)
Ampio Pharmaceuticals, Inc. (4)
AMYLIN PHARMACEUTICALS INC (4)
Amylyx Pharmaceuticals, Inc. (2)
AN2 Therapeutics, Inc. (2)
Anacor Pharmaceuticals, Inc. (3)
ANADYS PHARMACEUTICALS INC (1)
Anebulo Pharmaceuticals, Inc. (1)
Angion Biomedica Corp. (3)
ANI Pharma Inc (5)
Anthera Pharmaceuticals Inc (3)
Apimeds Pharmaceuticals US, Inc. (2)
APRICUS BIOSCIENCES, INC. (10)
Aquestive Therapeutics, Inc. (3)
Aralez Pharmaceuticals Inc. (3)
ARIAD PHARMACEUTICALS INC (5)
ARTELO BIOSCIENCES, INC. (3)
ARVINAS, INC. (3)
Assertio Therapeutics, Inc (2)
ATAI Life Sciences B.V. (1)
Atea Pharmaceuticals, Inc. (1)
Athira Pharma, Inc. (2)
AUXILIUM PHARMACEUTICALS INC (1)
AVADEL PHARMACEUTICALS PLC (2)
AVALON PHARMACEUTICALS INC (1)
AVANIR PHARMACEUTICALS, INC. (2)
AVENUE THERAPEUTICS, INC. (6)
Axsome Therapeutics, Inc. (4)
AYTU BIOSCIENCE, INC (10)
Baudax Bio, Inc. (2)
Bausch Health Companies Inc. (2)
Big Rock Partners Acquisition Corp. (4)
BIODELIVERY SCIENCES INTERNATIONAL INC (1)
Biofrontera Inc. (3)
Biohaven Ltd. (4)
BioPharmX Corp (8)
Blue Water Acquisition Corp. (7)
Braeburn Pharmaceuticals, Inc. (1)
Bright Green Corp (1)
Bristol-Myers Squibb (9)
CADENCE PHARMACEUTICALS INC (2)
Canbiola, Inc. (2)
Cancer Prevention Pharmaceuticals, Inc. (2)
Cara Therapeutics, Inc. (5)
CASSAVA SCIENCES INC (2)
Catalent Inc (9)
Celator Pharmaceuticals Inc (2)
CELGENE CORP (6)
Cerecor Inc. (7)
CHIASMA, INC (4)
CinCor Pharma, Inc. (2)
Cingulate Inc. (4)
Citius Pharmaceuticals, Inc. (7)
Clearside Biomedical, Inc. (3)
CNS Pharmaceuticals, Inc. (4)
Cocrystal Pharma, Inc. (4)
COGNITION THERAPEUTICS INC (4)
COLLEGIUM PHARMACEUTICAL, INC (4)
Context Therapeutics Inc. (1)
ContraVir Pharmaceuticals, Inc. (6)
Corcept Therapeutics Incorporated (3)
CorMedix Inc. (3)
CUBIST PHARMACEUTICALS INC (2)
CUMBERLAND PHARMACEUTICALS INC (1)
CymaBay Therapeutics, Inc. (9)
Cyteir Therapeutics, Inc. (1)
Dermata Therapeutics, Inc. (2)
DiCE MOLECULES HOLDINGS, LLC (2)
Dova Pharmaceuticals Inc. (2)
DURECT CORP (4)
Edgewise Therapeutics, Inc. (3)
Egalet Corp (3)
Elanco Animal Health Inc (4)
Eleison Pharmaceuticals Inc (1)
Elixir Pharmaceuticals, Inc. (1)
Eloxx Pharmaceuticals, Inc. (4)
Endo International plc (1)
Endo Pharmaceuticals Solutions Inc. (1)
Eton Pharmaceuticals, Inc. (4)
Evofem Biosciences, Inc. (6)
Evoke Pharma Inc (7)
Evolus, Inc. (7)
EYEGATE PHARMACEUTICALS INC (11)
EYENOVIA, INC. (6)
EyePoint Pharmaceuticals, Inc. (8)
EYETECH PHARMACEUTICALS INC (1)
Foamix Pharmaceuticals Ltd. (1)
Fulcrum Therapeutics, Inc. (5)
GRAYBUG VISION, INC. (2)
GUILFORD PHARMACEUTICALS INC (1)
GW PHARMACEUTICALS PLC (1)
Harmony Biosciences Holdings, Inc. (2)
HARROW HEALTH, INC. (8)
Haymaker Acquisition Corp. III (4)
Horizon Pharma plc (7)
Hoth Therapeutics, Inc. (5)
IDENIX PHARMACEUTICALS INC (4)
Ikena Oncology, Inc. (2)
IMARA Inc. (2)
INNOVATE BIOPHARMACEUTICALS, INC. (3)
Innoviva, Inc. (1)
Intersect ENT, Inc. (3)
Intra-Cellular Therapies, Inc. (8)
Iterum Therapeutics plc (2)
Jaguar Health, Inc. (7)
Jazz Pharmaceuticals plc (3)
Johnson & Johnson (6)
Journey Medical Corp (2)
Kala Pharmaceuticals, Inc. (3)
Kaleido Biosciences, Inc. (3)
KEMPHARM, INC (5)
Landos Biopharma, Inc. (1)
Lannett Company, Inc. (2)
Level Brands, Inc. (7)
Lexaria Bioscience Corp. (3)
Lilly (Eli) & Co. (15)
LIPELLA PHARMACEUTICALS INC (3)
Lipocine Inc. (3)
Liquidia Corp (3)
Liquidia Technologies Inc (3)
Longboard Pharmaceuticals, Inc. (3)
Lyra Therapeutics, Inc. (1)
MAP Pharmaceuticals, Inc. (2)
MARINUS PHARMACEUTICALS INC (8)
Menlo Therapeutics Inc. (2)
Merck (3)
Milestone Pharmaceuticals Inc. (3)
Mind Medicine (MindMed) Inc. (3)
MIRA PHARMACEUTICALS, INC. (2)
Molecular Insight Pharmaceuticals, Inc. (1)
Mylan N.V. (1)
MYnd Analytics, Inc. (4)
MyoKardia Inc (6)
Nabriva Therapeutics plc (2)
NEKTAR THERAPEUTICS (2)
Neos Therapeutics, Inc. (4)
Neuralstem, Inc. (11)
NEW RIVER PHARMACEUTICALS INC (1)
NGM BIOPHARMACEUTICALS INC (2)
NovaBay Pharmaceuticals, Inc. (5)
Novan, Inc. (4)
NPS PHARMACEUTICALS INC (4)
OCULAR THERAPEUTIX, INC (8)
Odonate Therapeutics, Inc. (3)
OMEROS CORP (8)
Omthera Pharmaceuticals, Inc. (1)
OncoMed Pharmaceuticals Inc (1)
Onconova Therapeutics, Inc. (10)
ONYX PHARMACEUTICALS INC (3)
OPIANT PHARMACEUTICALS, INC. (1)
OPTIMER PHARMACEUTICALS INC (2)
OptiNose, Inc. (6)
ORAMED PHARMACEUTICALS INC. (1)
Osmotica Pharmaceuticals plc (3)
OTONOMY, INC. (5)
Pacira Pharmaceuticals, Inc. (4)
Panacea Acquisition Corp (2)
Paratek Pharmaceuticals, Inc. (4)
PaxMedica, Inc. (4)
Perrigo (4)
Pfizer (8)
Phathom Pharmaceuticals, Inc. (4)
Phibro Animal Health Corporation (1)
Planet 13 Holdings Inc. (1)
PLIANT THERAPEUTICS, INC. (3)
PLx Pharma Inc. (7)
PONIARD PHARMACEUTICALS, INC. (1)
PREDIX PHARMACEUTICALS HOLDINGS INC (1)
Processa Pharmaceuticals, Inc. (2)
ProPhase Labs, Inc. (2)
PROVECTUS BIOPHARMACEUTICALS, INC. (1)
Provention Bio, Inc. (5)
Pulmatrix, Inc. (8)
QUATRX PHARMACEUTICALS CO (1)
Ra Pharmaceuticals, Inc. (3)
Rain Therapeutics Inc. (3)
Rani Therapeutics Holdings, Inc. (1)
REATA PHARMACEUTICALS INC (6)
Recro Pharma, Inc. (5)
RELMADA THERAPEUTICS, INC. (2)
resTORbio, Inc. (5)
Revance Therapeutics, Inc. (8)
Rib-X Pharmaceuticals, Inc. (1)
Roivant Sciences Ltd. (2)
Royalty Pharma plc (4)
Sagent Pharmaceuticals, Inc. (2)
SALIX PHARMACEUTICALS LTD (1)
SANCILIO PHARMACEUTICALS COMPANY, INC. (1)
Satsuma Pharmaceuticals, Inc. (1)
Scopus BioPharma Inc. (1)
scPharmaceuticals Inc. (4)
SCYNEXIS INC (6)
SenesTech, Inc. (5)
Sienna Biopharmaceuticals, Inc. (2)
Sonoma Pharmaceuticals, Inc. (6)
Strongbridge Biopharma plc (2)
Sucampo Pharmaceuticals, Inc. (2)
Supernus Pharmaceuticals, Inc. (2)
SYNERGY PHARMACEUTICALS, INC. (5)
Tarsus Pharmaceuticals, Inc. (4)
Telomir Pharmaceuticals, Inc. (2)
Tenzing Acquisition Corp. (6)
Terns Pharmaceuticals, Inc. (4)
TETRALOGIC PHARMACEUTICALS CORP (1)
TETRAPHASE PHARMACEUTICALS INC (5)
TEVA PHARMACEUTICAL INDUSTRIES LTD (2)
TFF Pharmaceuticals, Inc. (4)
The Medicines Company (2)
TherapeuticsMD, Inc. (12)
Theravance Biopharma, Inc. (5)
Theseus Pharmaceuticals, Inc. (1)
Tilray, Inc. (4)
TITAN PHARMACEUTICALS INC (8)
Trevi Therapeutics, Inc. (3)
Tribute Pharmaceuticals Canada Inc. (1)
Tricida, Inc. (2)
Trulieve Cannabis Corp. (1)
Urovant Sciences Ltd. (1)
Valera Pharmaceuticals Inc (1)
Vallon Pharmaceuticals, Inc. (2)
Ventyx Biosciences, Inc. (1)
Verona Pharma plc (1)
Verrica Pharmaceuticals Inc. (5)
VIA Pharmaceuticals, Inc. (1)
Viamet Pharmaceuticals Holdings LLC (1)
VICURON PHARMACEUTICALS INC (1)
Virpax Pharmaceuticals, Inc. (2)
Vitae Pharmaceuticals, Inc (3)
VIVUS INC (3)
Wave Life Sciences Ltd. (7)
XERIS PHARMACEUTICALS INC (3)
Zoetis (6)
ZOGENIX, INC. (7)
Zomedica Pharmaceuticals Corp. (2)
Zynerba Pharmaceuticals, Inc. (3)

Recent Contracts

Underwriting Agreement, dated December 15, 2024, by and among the Company and Leerink Partners LLC, Stifel, Nicolaus & Company, Incorporated and Oppenheimer & Co. Inc (Trevi Therapeutics, Inc., Filed With SEC on December 16, 2024)
Form of Underwriting Agreement by and between Palisade Bio, Inc. and Ladenburg Thalmann & Co. Inc (Neuralstem, Inc., Filed With SEC on December 16, 2024)
Form of Underwriting Agreement (Apimeds Pharmaceuticals US, Inc., Filed With SEC on December 9, 2024)
Form of Underwriting Agreement (Neuralstem, Inc., Filed With SEC on December 9, 2024)
Form of Underwriting Agreement (Neuralstem, Inc., Filed With SEC on December 5, 2024)
Underwriting Agreement, dated November 20, 2024, by and between the Company and Jefferies LLC (Verrica Pharmaceuticals Inc., Filed With SEC on November 21, 2024)
Underwriting Agreement dated November 7, 2024 between ProPhase Labs, Inc. and ThinkEquity LLC (ProPhase Labs, Inc., Filed With SEC on November 13, 2024)
Underwriting Agreement, dated October 30, 2024, by and among Harmony Biosciences Holdings, Inc., J.P. Morgan Securities LLC, and certain selling shareholders named therein (Harmony Biosciences Holdings, Inc., Filed With SEC on November 1, 2024)
Underwriting Agreement by and between the Company and JonesTrading Institutional Services LLC. dated October 30, 2024 (GRAYBUG VISION, INC., Filed With SEC on October 31, 2024)
Underwriting Agreement, dated October 29, 2024, by and between EyePoint Pharmaceuticals, Inc. and J.P. Morgan Securities LLC (EyePoint Pharmaceuticals, Inc., Filed With SEC on October 31, 2024)
Underwriting Agreement, dated as of September 30, 2024, by and between the Company and J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC, as representatives of the several... (Biohaven Ltd., Filed With SEC on October 2, 2024)
Underwriting Agreement, dated September 25, 2024, by and between the Company and J.P. Morgan Securities LLC and Leerink Partners LLC (Wave Life Sciences Ltd., Filed With SEC on September 26, 2024)
Form of Underwriting Agreement (Apimeds Pharmaceuticals US, Inc., Filed With SEC on September 25, 2024)
Underwriting Agreement, dated as of September 11, 2024, among the Issuer, the Company, the Subsidiary Guarantors, BofA Securities Inc. as representatives of the several... (Perrigo, Filed With SEC on September 17, 2024)
Underwriting Agreement, dated September 10, 2024, between Terns Pharmaceuticals, Inc. and Jefferies LLC and TD Securities (USA) LLC, as representatives of the several underwriters... (Terns Pharmaceuticals, Inc., Filed With SEC on September 12, 2024)
Underwriting Agreement by and between Liquidia Corporation and BofA Securities, Inc., as representative of the underwriters named therein, dated September 11, 2024 (Liquidia Corp, Filed With SEC on September 12, 2024)
Underwriting Agreement, dated August 20, 2024, between Reviva Pharmaceuticals Holdings, Inc. and Titan Partners Group LLC (Tenzing Acquisition Corp., Filed With SEC on August 21, 2024)
Underwriting Agreement, dated August 19, 2024, by and among Phathom Pharmaceuticals, Inc. and Evercore Group L.L.C., Stifel, Nicolaus & Company, Incorporated and Guggenheim... (Phathom Pharmaceuticals, Inc., Filed With SEC on August 19, 2024)
Underwriting Agreement, dated August 12, 2024, among Eli Lilly and Company and BNP Paribas Securities Corp., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, J.P. Morgan... (Lilly (Eli) & Co., Filed With SEC on August 14, 2024)
Underwriting Agreement, dated August 12, 2024, between scPharmaceuticals Inc., Leerink Partners LLC and TD Securities (USA) LLC, as representatives of the several underwriters... (scPharmaceuticals Inc., Filed With SEC on August 13, 2024)
Underwriting Agreement by and between Mind Medicine (MindMed) Inc. and Leerink Partners LLC and Evercore Group L.L.C., as representatives of the underwriters named therein, dated... (Mind Medicine (MindMed) Inc., Filed With SEC on August 12, 2024)
Underwriting Agreement, dated as of August 8, 2024, by and between Zevra Therapeutics, Inc. and Cantor Fitzgerald & Co. and William Blair & Company, L.L.C (KEMPHARM, INC, Filed With SEC on August 9, 2024)
Underwriting Agreement, dated July 26, 2024, by and between NovaBay Pharmaceuticals, Inc. and Ladenburg Thalmann & Co., Inc (NovaBay Pharmaceuticals, Inc., Filed With SEC on July 29, 2024)
Form of Underwriting Agreement (NovaBay Pharmaceuticals, Inc., Filed With SEC on July 10, 2024)
Underwriting Agreement, dated June 28, 2024, between Elicio Therapeutics, Inc. and JonesTrading Institutional Services LLC, as representative of the several underwriters named... (Angion Biomedica Corp., Filed With SEC on July 1, 2024)
Underwriting Agreement, dated as of June 3, 2024, by and among Royalty Pharma plc, Royalty Pharma Holdings Ltd, RP Management, LLC and the underwriters named therein (Royalty Pharma plc, Filed With SEC on June 4, 2024)
Underwriting Agreement, dated May 14, 2024, among Johnson & Johnson and J.P. Morgan Securities plc, Citigroup Global Markets Limited, Deutsche Bank AG, London Branch and the... (Johnson & Johnson, Filed With SEC on May 20, 2024)
Underwriting Agreement Standard Provisions (Debt), dated May 13, 2024 (Johnson & Johnson, Filed With SEC on May 20, 2024)
Underwriting Agreement, dated May 13, 2024, among Johnson & Johnson and J.P. Morgan Securities LLC, BofA Securities, Inc. and Citigroup Global Markets Inc., as representatives of... (Johnson & Johnson, Filed With SEC on May 20, 2024)
Underwriting Agreement, dated as of April 17, 2024, by and between the Company and J.P. Morgan Securities LLC, as representative of the several underwriters (Biohaven Ltd., Filed With SEC on April 22, 2024)
Underwriting Agreement, dated April 18, 2024, by and between NRx Pharmaceuticals, Inc. and EF Hutton LLC (Big Rock Partners Acquisition Corp., Filed With SEC on April 19, 2024)
Underwriting Agreement, dated April 17, 2024, by and among the Company, J.P. Morgan Securities LLC, Leerink Partners LLC, BofA Securities, Inc., Morgan Stanley & Co. LLC and RBC... (Intra-Cellular Therapies, Inc., Filed With SEC on April 18, 2024)
Underwriting Agreement, dated March 19, 2024, by and among Aquestive Therapeutics, Inc. and Leerink Partners LLC and Piper Sandler & Co., as representatives of the several... (Aquestive Therapeutics, Inc., Filed With SEC on March 21, 2024)
Underwriting Agreement, dated March 11, 2024, by and between Evolus, Inc. and Leerink Partners, LLC and Stifel, Nicolaus & Company, Incorporated (Evolus, Inc., Filed With SEC on March 13, 2024)
Underwriting Agreement, dated as of March 11, 2024, by and between Cognition Therapeutics, Inc. and Titan Partners Group LLC, as representative of the underwriters (COGNITION THERAPEUTICS INC, Filed With SEC on March 13, 2024)
Underwriting Agreement, dated March 7, 2024, by and between Mind Medicine (MindMed) Inc. and Leerink Partners LLC and Cantor Fitzgerald & Co (Mind Medicine (MindMed) Inc., Filed With SEC on March 11, 2024)
Underwriting Agreement, dated March 5, 2024, by and between Planet 13 Holdings Inc. and Canaccord Genuity LLC, as representative of the several underwriters listed in Schedule A... (Planet 13 Holdings Inc., Filed With SEC on March 7, 2024)
Underwriting Agreement, dated March 4, 2024, by and between the Company and the Underwriter (Revance Therapeutics, Inc., Filed With SEC on March 5, 2024)
Underwriting Agreement, dated February 28, 2024, by and between the Company and Piper Sandler & Co (Milestone Pharmaceuticals Inc., Filed With SEC on March 4, 2024)
Underwriting Agreement, dated February 29, 2024, by and among the Company, Goldman Sachs & Co. LLC, BofA Securities, Inc. and Guggenheim Securities, LLC (Tarsus Pharmaceuticals, Inc., Filed With SEC on March 1, 2024)